Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Inv. presentation

KIORA PHARMACEUTICALS INC (KPRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/03/2023 4 Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 30,000 shares @ $0
Granted 60,000 options to buy @ $0.5677, valued at $34.1k
10/03/2023 4 Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 62,500 shares @ $0
Granted 125,000 options to buy @ $0.5677, valued at $71k
10/03/2023 4 Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 75,000 shares @ $0
Granted 150,000 options to buy @ $0.5677, valued at $85.2k
10/03/2023 4 TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 5,000 options to buy @ $0.5677, valued at $2.8k
10/03/2023 4 Shapiro Aron (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 5,000 options to buy @ $0.5677, valued at $2.8k
10/03/2023 4 Stengone Carmine N. (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 8,000 options to buy @ $0.5677, valued at $4.5k
10/03/2023 4 Hollander David (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted options to buy @ $0.5677, valued at $0
10/03/2023 4 Gayron Kenneth L (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 5,000 options to buy @ $0.5677, valued at $2.8k
10/03/2023 4 Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 5,000 options to buy @ $0.5677, valued at $2.8k
09/27/2023 8-K Quarterly results
08/10/2023 3 Stengone Carmine N. (Director) has filed a Form 3 on KIORA PHARMACEUTICALS INC
08/08/2023 8-K Quarterly results
Docs: "Kiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress"
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/20/2023 8-K Quarterly results
07/11/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
06/06/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs: "1,447,628 SHARES OF COMMON STOCK, 3,908 SHARES OF SERIES F CONVERTIBLE PREFERRED STOCK",
"KIORA PHARMACEUTICALS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS",
"KIORA PHARMACEUTICALS, INC. and VSTOCK TRANSFER, LLC, as Warrant Agent",
"Kiora Pharmaceuticals Announces Closing of"
06/02/2023 424B1 Form 424B1 - Prospectus [Rule 424(b)(1)]:
06/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/15/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
05/12/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/09/2023 8-K Quarterly results
Docs: "Kiora Pharmaceuticals Reports First Quarter"
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
04/27/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
03/23/2023 8-K Quarterly results
Docs: "Kiora Pharmaceuticals Reports 2022 Financial Results&#59; Provides Update on Clinical Development Progress"
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 4 Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 8,000 options to buy @ $3.83, valued at $30.6k
03/07/2023 4 Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 2,400 shares @ $0
Granted 1,600 options to buy @ $3.83, valued at $6.1k
03/07/2023 4 Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 15,600 shares @ $3.83, valued at $59.7k
Granted 10,400 options to buy @ $3.83, valued at $39.8k
03/07/2023 4 Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns: Granted 15,600 shares @ $0
Granted 10,400 options to buy @ $3.83, valued at $39.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy